Remove 2023 Remove Drug Development Remove Research
article thumbnail

2023 cancer research highlights: Drug development at its best

Drug Discovery World

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Research into new cancer drugs remain strong.

article thumbnail

Conversations from Cancer Research Horizons’ Innovation Summit 2023 

Drug Discovery World

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. DDW’s Megan Thomas spoke to a range of attendees.

Research 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DDW top reads in 2023

Drug Discovery World

DDW’s top 10 most popular articles for 2023 reflect the key subjects in drug discovery and development. Other biotechnologies coming to the fore this year were antibody-drug conjugates and CRISPR gene editing. Other biotechnologies coming to the fore this year were antibody-drug conjugates and CRISPR gene editing.

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

As 2023 draws to a close, DDW’s Multimedia Editor and podcast host Megan Thomas rounds up all the free episodes of the DDW podcast that were released. You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. Developing. DDW Highlights Innovative. Listen here. Listen here. Listen here.

article thumbnail

Breakthrough drug discovery research collaboration in obesity

Drug Discovery World

Flagship Pioneering and ProFound Therapeutics have announced a collaboration to conduct foundational research to identify potential next-generation first-in-class therapies for the treatment of obesity. The collaboration is the first initiated under Flagship’s Pioneering Medicines strategic partnership with Pfizer announced in July 2023.

Research 147
article thumbnail

Predicting Drug Development in 2023

EG Life Sciences

The year 2022 reflected a transformative path for the drug development industry. It is without a doubt that 2022 predicted change and opportunity in biopharma and biotech clinical trials in 2023. Approval processes were slow in comparison to 2020 and 2021, where 53 and 50 approvals were achieved respectively.

article thumbnail

Could NfL accelerate drug development for neurodegenerative diseases?

Drug Discovery World

Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. Impact on the investment landscape In neurodegeneration, we are looking for the ‘needle in a haystack’ drug.